Cointime

Bell Biosystems

company

About

Bell Biosystems, a research-stage biotechnology company, develops tools that accelerate innovations in oncology and cell therapy research.

  • 1 - 10

Highlights

Total Funding Amount
$3.81M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series A
Last Funding Money Raised
$3.81M
Industries
Biotechnology,Clinical Trials,Therapeutics
Founded date
Jan 1, 2009
Number Of Employee
1 - 10
Operating Status
Active

Bell Biosystems is a biotechnology company based in Berkeley, CA, and focused on developing tools for the tracking and imaging of cellular therapies. Bell combines expertise in stem cell research, cell biology, biomedical imaging, molecular biology and clinical regenerative medicine. Our vision is to create tools that accelerate the "bench-to-bedside" progress of innovations in cell therapy pre-clinical and clinical delivery and tracking of transplanted cells.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$3.81M
Bell Biosystems has raised a total of $3.81M in funding over 2 rounds. Their latest funding was raised on Apr 13, 2015 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 13, 2015 Series A $3.81M 1 LiteCap — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Bell Biosystems is funded by 1 investors. LiteCap are the most recent investors.
Investor Name Lead Investor Funding Round
LiteCap Yes Series A
Cointime
Content
Company